uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted April 17, 2020

Joint Pain Supplement Isoprex Settles Charges of Making False Claims

On April 16, 2020, Renaissance Health Publishing, LLC, agreed to halt their allegedly deceptive advertising claims about their Isoprex supplement that targeted older consumers nationwide after the Federal Trade Commission (FTC) filed a complaint. As part of the settlement, the company is barred from making false and unsubstantiated health claims about the products, and will pay $100,000.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at